{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:59:48Z","timestamp":1703084388581},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This research utilized an external longitudinal dataset of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) to compare and validate various predictive models that support the current recommendations to select the most effective predictive risk models to estimate short- and long-term mortality and facilitate decision-making about preferable therapeutics for HBV-ACLF patients. Twelve ACLF prognostic models were developed after a systematic literature search using the longitudinal data of 232 HBV-ACLF patients on the waiting list for liver transplantation (LT). Four statistical measures, the constant (A) and slope (B) of the fitted line, the area under the curve (C) and the net benefit (D), were calculated to assess and compare the calibration, discrimination and clinical usefulness of the 12 predictive models. According to the model calibration and discrimination, the logistic regression models (LRM2) and the United Kingdom model of end-stage liver disease(UKELD) were selected as the best predictive models for both 3-month and 5-year outcomes. The decision curve summarizes the benefits of intervention relative to the costs of unnecessary treatment. After the comprehensive validation and comparison of the currently used models, LRM2 was confirmed as a markedly effective prognostic model for LT-free HBV-ACLF patients for assisting targeted and standardized therapeutic decisions.<\/jats:p>","DOI":"10.1038\/srep33389","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T11:13:01Z","timestamp":1474024381000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics"],"prefix":"10.1038","volume":"6","author":[{"given":"Yi","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"BFsrep33389_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3, 269\u201382 (2009).","journal-title":"Hepatol Int"},{"key":"BFsrep33389_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1440-1746.2011.06971.x","volume":"27","author":"WK Seto","year":"2012","unstructured":"Seto, W. K., Lai, C. L. & Yuen, M. F. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol 27, 662\u20139 (2012).","journal-title":"J Gastroenterol Hepatol"},{"key":"BFsrep33389_CR3","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s10620-010-1257-7","volume":"55","author":"YL Cui","year":"2010","unstructured":"Cui, Y. L. et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci. 55, 2373\u201380 (2010).","journal-title":"Dig Dis Sci."},{"key":"BFsrep33389_CR4","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.transproceed.2008.05.071","volume":"40","author":"AW Avolio","year":"2008","unstructured":"Avolio, A. W. et al. Liver transplantation for hepatitis B virus patients: Long-term results of three therapeutic approaches. Transplantation Proceedings 40, 1961\u20131964 (2008).","journal-title":"Transplantation Proceedings"},{"key":"BFsrep33389_CR5","first-page":"643","volume":"14","author":"LJ Li","year":"2006","unstructured":"Li, L. J. Diagnostic and treatment guidelines for Iiver failure. Zhonghua Gan Zang Bing Za Zhi 14, 643\u2013646 (2006).","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"BFsrep33389_CR6","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1097\/MD.0000000000000338","volume":"93","author":"G Qin","year":"2014","unstructured":"Qin, G. et al. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine (Baltimore) 93, e338 (2014).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep33389_CR7","doi-asserted-by":"publisher","first-page":"e2145","DOI":"10.1038\/cddis.2016.45","volume":"7","author":"AP Komarov","year":"2016","unstructured":"Komarov, A. P. et al. Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure. Cell Death Dis. 7, e2145 (2016).","journal-title":"Cell Death Dis."},{"key":"BFsrep33389_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc, M. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864\u201371 (2000).","journal-title":"Hepatology"},{"key":"BFsrep33389_CR9","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins, S. W. et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130, 1652\u20131660 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep33389_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim, W. R. et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359, 1018\u201326 (2008).","journal-title":"N Engl J Med"},{"key":"BFsrep33389_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1478-3231.2007.01445.x","volume":"27","author":"TI Huo","year":"2007","unstructured":"Huo, T. I. et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int. 27, 498\u2013506 (2007).","journal-title":"Liver Int."},{"key":"BFsrep33389_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/lt.21197","volume":"13","author":"A Luca","year":"2007","unstructured":"Luca, A. et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 13, 1174\u201380 (2007).","journal-title":"Liver Transpl"},{"key":"BFsrep33389_CR13","doi-asserted-by":"crossref","unstructured":"Yan, H. et al. A novel integrated Model for End-Stage Liver Disease model predicts short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure patients. Hepatol Res (2014).","DOI":"10.1111\/hepr.12362"},{"key":"BFsrep33389_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2008.08.004","volume":"135","author":"P Sharma","year":"2008","unstructured":"Sharma, P., Schaubel, D. E., Sima, C. S., Merion, R. M. & Lok, A. S. Re-weighting the model for end-stage liver disease score components. Gastroenterology 135, 1575\u201381 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep33389_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/gut.2007.131730","volume":"57","author":"J Neuberger","year":"2008","unstructured":"Neuberger, J. et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57, 252\u20137 (2008).","journal-title":"Gut"},{"key":"BFsrep33389_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-6143.2008.02491.x","volume":"9","author":"JB Halldorson","year":"2009","unstructured":"Halldorson, J. B., Bakthavatsalam, R., Fix, O., Reyes, J. D. & Perkins, J. D. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor\/recipient matching. Am J Transplant 9, 318\u201326 (2009).","journal-title":"Am J Transplant"},{"key":"BFsrep33389_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60, 646\u20139 (1973).","journal-title":"Br J Surg"},{"key":"BFsrep33389_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/lt.20560","volume":"12","author":"TI Huo","year":"2006","unstructured":"Huo, T. I. et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 12, 65\u201371 (2006).","journal-title":"Liver Transpl"},{"key":"BFsrep33389_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2893.2008.01046.x","volume":"16","author":"QF Sun","year":"2009","unstructured":"Sun, Q. F. et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 16, 464\u201370 (2009).","journal-title":"J Viral Hepat"},{"key":"BFsrep33389_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cgh.2010.12.027","volume":"9","author":"MH Zheng","year":"2011","unstructured":"Zheng, M. H. et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 9, 351\u2013356 e3 (2011).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFsrep33389_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/lt.22093","volume":"16","author":"M Biselli","year":"2010","unstructured":"Biselli, M. et al. Six Score Systems to Evaluate Candidates with Advanced Cirrhosis for Orthotopic Liver Transplant: Which Is the Winner? Liver Transplantation 16, 964\u2013973 (2010).","journal-title":"Liver Transplantation"},{"key":"BFsrep33389_CR22","doi-asserted-by":"publisher","first-page":"E395","DOI":"10.1111\/j.1399-0012.2012.01688.x","volume":"26","author":"CP Marroni","year":"2012","unstructured":"Marroni, C. P. et al. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Clinical Transplantation 26, E395\u2013E401 (2012).","journal-title":"Clinical Transplantation"},{"key":"BFsrep33389_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3892\/mmr.2014.1983","volume":"9","author":"YH Xun","year":"2014","unstructured":"Xun, Y. H. et al. Prognostic performance of a series of model for end-stage liver disease and respective Delta scores in patients with hepatitis B acute-on-chronic liver failure. Molecular Medicine Reports 9, 1559\u20131568 (2014).","journal-title":"Molecular Medicine Reports"},{"key":"BFsrep33389_CR24","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3748\/wjg.v17.i29.3448","volume":"17","author":"K Huang","year":"2011","unstructured":"Huang, K. et al. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 17, 3448\u201352 (2011).","journal-title":"World J Gastroenterol"},{"key":"BFsrep33389_CR25","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.25011\/cim.v35i2.16291","volume":"35","author":"YB Zheng","year":"2012","unstructured":"Zheng, Y. B. et al. Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Clin Invest Med. 35, E75\u201385 (2012).","journal-title":"Clin Invest Med."},{"key":"BFsrep33389_CR26","doi-asserted-by":"crossref","unstructured":"Mori, T., Osaki, Y., Oba-Yabana, I. & Ito, S. Diuretic Usage for Protection against End-Organ Damage in Liver Cirrhosis and Heart Failure. Hepatol Res (2016).","DOI":"10.1111\/hepr.12700"},{"key":"BFsrep33389_CR27","doi-asserted-by":"crossref","unstructured":"Ribeiro, S. et al. Liver iron is a major regulator of hepcidin gene expression via BMP\/SMAD pathway in a rat model of chronic renal failure under treatment with high rHuEPO doses. Biofactors (2016).","DOI":"10.1093\/ndt\/gfw166.05"},{"key":"BFsrep33389_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","volume":"131","author":"J Fernandez","year":"2006","unstructured":"Fernandez, J. et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131, 1049\u201356; quiz 1285 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep33389_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hep.21352","volume":"44","author":"J Fernandez","year":"2006","unstructured":"Fernandez, J. et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 44, 1288\u201395 (2006).","journal-title":"Hepatology"},{"key":"BFsrep33389_CR30","doi-asserted-by":"crossref","unstructured":"Cardoso, B. A., Leal, R., Sa, H. & Campos, M. Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course. BMJ Case Rep. 2016 (2016).","DOI":"10.1136\/bcr-2016-214392"},{"key":"BFsrep33389_CR31","doi-asserted-by":"publisher","first-page":"e3145","DOI":"10.1097\/MD.0000000000003145","volume":"95","author":"CH Wang","year":"2016","unstructured":"Wang, C. H., Sun, C. K., Jiang, J. S. & Tsai, M. H. Tumor-Like Liver Abscess Mimicking Malignancy With Lung Metastases in a Patient With Acute Renal Failure: A Case Report. Medicine (Baltimore) 95, e3145 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep33389_CR32","doi-asserted-by":"crossref","unstructured":"Nian, X. et al. Association between hepatitis B virus basal core promoter\/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis. Hepatol Int (2016).","DOI":"10.1007\/s12072-016-9716-7"},{"key":"BFsrep33389_CR33","doi-asserted-by":"crossref","unstructured":"Luca, A., Miraglia, R., Maruzzelli, L., D\u2019Amico, M. & Tuzzolino, F. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors. Radiology, 151625 (2016).","DOI":"10.1148\/radiol.2016151625"},{"key":"BFsrep33389_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","volume":"8","author":"C Valerio","year":"2016","unstructured":"Valerio, C., Theocharidou, E., Davenport, A. & Agarwal, B. Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion. World J Hepatol 8, 345\u201354 (2016).","journal-title":"World J Hepatol"},{"key":"BFsrep33389_CR35","doi-asserted-by":"crossref","unstructured":"Maloney, P. R. et al. Intracranial Pressure Monitoring in Acute Liver Failure: Institutional Case Series. Neurocrit Care (2016).","DOI":"10.1007\/s12028-016-0261-y"},{"key":"BFsrep33389_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/17474124.2014.906899","volume":"8","author":"FL Wu","year":"2014","unstructured":"Wu, F. L. et al. Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review. Expert Rev Gastroenterol Hepatol 8, 623\u201332 (2014).","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"BFsrep33389_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg, E. W. et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128\u201338 (2010).","journal-title":"Epidemiology"},{"key":"BFsrep33389_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers, A. J. & Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26, 565\u201374 (2006).","journal-title":"Med Decis Making"},{"key":"BFsrep33389_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina, M. J., D\u2019Agostino, R. B. Sr., D\u2019Agostino, R. B. Jr. & Vasan, R. S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27, 157\u201372; discussion 207\u201312 (2008).","journal-title":"Stat Med"},{"key":"BFsrep33389_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina, M. J., D\u2019Agostino, R. B. Sr. & Steyerberg, E. W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30, 11\u201321 (2011).","journal-title":"Stat Med"},{"key":"BFsrep33389_CR41","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/jnci\/djp353","volume":"101","author":"SG Baker","year":"2009","unstructured":"Baker, S. G. Putting risk prediction in perspective: relative utility curves. J Natl Cancer Inst. 101, 1538\u201342 (2009).","journal-title":"J Natl Cancer Inst."},{"key":"BFsrep33389_CR42","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1200\/JCO.2014.58.0092","volume":"33","author":"SG Baker","year":"2015","unstructured":"Baker, S. G. & Kramer, B. S. Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs. Journal Of Clinical Oncology 33, 2578\u2013U150 (2015).","journal-title":"Journal Of Clinical Oncology"},{"key":"BFsrep33389_CR43","doi-asserted-by":"publisher","first-page":"e2477","DOI":"10.1097\/MD.0000000000002477","volume":"95","author":"WC Lee","year":"2016","unstructured":"Lee, W. C. & Wu, Y. C. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves. Medicine (Baltimore) 95, e2477 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep33389_CR44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jclinepi.2004.06.017","volume":"58","author":"Y Vergouwe","year":"2005","unstructured":"Vergouwe, Y., Steyerberg, E. W., Eijkemans, M. J. C. & Habbema, J. D. F. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. Journal Of Clinical Epidemiology 58, 475\u2013483 (2005).","journal-title":"Journal Of Clinical Epidemiology"},{"key":"BFsrep33389_CR45","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/lt.500030613","volume":"3","author":"MR Lucey","year":"1997","unstructured":"Lucey, M. R. et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3, 628\u201337 (1997).","journal-title":"Liver Transpl Surg"},{"key":"BFsrep33389_CR46","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg, E. W. & Vergouwe, Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 35, 1925\u201331 (2014).","journal-title":"Eur Heart J"},{"key":"BFsrep33389_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0272989X9301300107","volume":"13","author":"ME Miller","year":"1993","unstructured":"Miller, M. E., Langefeld, C. D., Tierney, W. M., Hui, S. L. & McDonald, C. J. Validation of probabilistic predictions. Med Decis Making 13, 49\u201358 (1993).","journal-title":"Med Decis Making"},{"key":"BFsrep33389_CR48","doi-asserted-by":"crossref","unstructured":"Hosmer, D. W. J., Lemeshow, S. & Sturdivant, R. Applied Logistic Regression 3nd edn, (John Wiley & Sons, 2013).","DOI":"10.1002\/9781118548387"},{"key":"BFsrep33389_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2015.37","volume":"313","author":"M Fitzgerald","year":"2015","unstructured":"Fitzgerald, M., Saville, B. R. & Lewis, R. J. Decision Curve Analysis. Jama-Journal Of the American Medical Association 313, 409\u2013410 (2015).","journal-title":"Jama-Journal Of the American Medical Association"},{"key":"BFsrep33389_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1198\/000313007X247643","volume":"61","author":"SG Baker","year":"2007","unstructured":"Baker, S. G. & Kramer, B. S. Peirce, Youden, and receiver operating characteristic curves. American Statistician 61, 343\u2013346 (2007).","journal-title":"American Statistician"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33389","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:02:01Z","timestamp":1672902121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep33389"],"URL":"https:\/\/doi.org\/10.1038\/srep33389","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]},"assertion":[{"value":"16 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2016","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The HTML version of this Article previously published omitted Gang Qin as a corresponding author. This has now been corrected in the HTML; the PDF version of the paper was correct from the time of publication.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33389"}}